已收盘 02-06 16:00:00 美东时间
+0.020
+1.35%
Gainers INNEOVA Holdings (NASDAQ:INEO) stock increased by 16.4% to $0.61 durin...
2025-12-23 20:05
Brilliant Earth Group (NASDAQ:BRLT) reported quarterly earnings of $0.02 per share which met the analyst consensus estimate. This is unchanged from the same period last year. The company reported quarterly sales of
2025-11-05 19:45
今日重点评级关注:HC Wainwright & Co.:维持Unicycive Therapeutics"买入"评级,目标价从9美元升至22美元;花旗:维持Arcus Biosciences"买入"评级,目标价从54美元升至56美元
2025-10-30 14:22
Telsey Advisory Group analyst Dana Telsey maintains Brilliant Earth Group (NASDAQ:BRLT) with a Market Perform and maintains $2 price target.
2025-10-29 18:59
Gainers Super X AI Technology (NASDAQ:SUPX) shares increased by 13.5% to $66.0...
2025-10-13 20:09
Brilliant Earth Group has launched a second collection in collaboration with Dr. Jane Goodall, featuring limited-edition fine jewelry made with 99% repurposed gold and lab-grown diamonds. The collection highlights ethical luxury and supports conservation efforts, with 10% of proceeds benefiting the Jane Goodall Legacy Fund. The partnership combines artistry with activism, aiming to inspire positive change and promote sustainability in the luxury ...
2025-09-23 13:00
Brilliant Earth Group (NASDAQ:BRLT) filed $200M mixed securities shelf. Filing More on Brilliant Earth Group Brilliant Earth: Special Dividends Don't Create Long-Term Value Brilliant Earth raises 2025...
2025-09-09 04:54
Tariffs on Indian goods could benefit American brands in fashion, jewelry, and auto parts, but there are risks and potential retaliations.
2025-08-28 03:37
Brilliant Earth Group announced its participation in several upcoming investor events. On August 19, 2025, the company will attend the Lytham Partners 2025 Consumer & Technology Investor Summit with a webcast available at 3:00pm ET. On August 26, 2025, management will host a fireside chat at the 16th Annual Midwest IDEAS Investor Conference in Chicago. The company will also participate in the Goldman Sachs 32nd Annual Global Retailing Conference ...
2025-08-14 21:29
今日重点评级关注:HC Wainwright & Co.:维持FibroGen"买入"评级,目标价从10美元升至43美元;摩根大通:维持Cogent Biosciences"超配"评级,目标价从29美元升至30美元
2025-08-08 09:34